News
- Amarantus Provides Recapitalization Update to Shareholders
11/18/2019 / 14:30 - GlobeNewswire
-
- Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with Amyloid PET
11/14/2019 / 17:02 - GlobeNewswire
-
- Vaxart Announces Third Quarter 2019 Financial Results and Provides Corporate Update
11/12/2019 / 22:45 - GlobeNewswire
-
- Prevail Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights
11/12/2019 / 15:30 - GlobeNewswire
-
- Vaxart Hosting Key Opinion Leader Meeting on the Health Economics of Norovirus Disease
11/06/2019 / 14:00 - GlobeNewswire
-
- Global Primary Cells Market Analysis, Trends, and Forecasts Report 2019
10/30/2019 / 11:17 - GlobeNewswire
-
- Worldwide Cell Based Assay & High Content Screening Market Forecasts to 2024 - Candidate Growth, Immuno-oncology, Genomic Blizzard, Technology Convergence, The Insurance Effect
10/29/2019 / 11:55 - GlobeNewswire
-
- Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products
10/24/2019 / 15:34 - GlobeNewswire
-
- Mesoblast and Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast’s Potential First United States Allogeneic Cell Therapy
10/17/2019 / 00:17 - GlobeNewswire
-
- Japan Respiratory Diseases, 2019: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
10/10/2019 / 12:20 - GlobeNewswire